CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Medical Devices (6162)
Mitralign is developing a catheter-based technology for percutaneous treatment of functional mitral regurgitation. The Mitralign system emulates surgical annuloplasty delivering a series of surgical implants directly into the mitral annulus by means ...Show all
Company (Alive / Active)
Phone: 978-863-2400
3 Highwood Drive
Tewksbury, 01876
Massachusetts, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Mitralign | $153.7M | Feb 20, 2018 |
| LuMend | $46.9M | Sep 21, 2005 |
| Viacor | $14.8M | Apr 20, 2010 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| System and method for reducing tricuspid regurgitation | Dec 29, 2016 | Nov 10, 2020 | Patent |
| System and method for reshaping right heart | Dec 29, 2016 | Aug 25, 2020 | Patent |
| Method and system for closing left atrial appendage | May 26, 2017 | Jul 07, 2020 | Patent |
| Tissue anchor and anchoring system | Aug 18, 2017 | Jun 30, 2020 | Patent |
| Translation catheters, systems, and methods of use thereof | Jul 06, 2017 | Jun 16, 2020 | Patent |
